Home Cart Sign in  
Chemical Structure| 376348-65-1 Chemical Structure| 376348-65-1

Structure of Maraviroc
CAS No.: 376348-65-1

Chemical Structure| 376348-65-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Maraviroc is a selective CCR5 antagonist (IC50= 6.4 nM) and displays potent anti-HIV-1 activity.

Synonyms: UK-427857

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Maraviroc

CAS No. :376348-65-1
Formula : C29H41F2N5O
M.W : 513.67
SMILES Code : O=C(C1CCC(F)(F)CC1)N[C@H](C2=CC=CC=C2)CCN3[C@@]4([H])C[C@H](N5C(C(C)C)=NN=C5C)C[C@]3([H])CC4
Synonyms :
UK-427857
MDL No. :MFCD13188530
InChI Key :GSNHKUDZZFZSJB-HLMSNRGBSA-N
Pubchem ID :3002977

Safety of Maraviroc

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Maraviroc

GPCR

Isoform Comparison

Biological Activity

Target
  • CCR

    MIP-1α, IC50:3.3 nM

    MIP-1β, IC50:5.2 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
CD14+ monocytes 0.1-100 μM 1 hour Maraviroc reduced the migration of monocytes induced by E-BM-MSC conditioned medium PMC6395337
MUG-Chor1 cells 30 µM 48 hours Blocking the CCL5–CCR5 axis significantly inhibited the migration and invasion of chordoma cells PMC10151997
THP-1 cells 30 µM 48 hours Blocking the CCL5–CCR5 axis significantly inhibited the migration and invasion of THP-1 cells PMC10151997

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Prenatal VPA exposure mouse model Drinking water 2.5 mg/kg 4 consecutive days Maraviroc significantly suppressed neural circuit dysfunction and post-developmental behavioral disorders induced by prenatal VPA exposure. PMC9335995
Nude mice L-540 tumor cell xenograft model Intraperitoneal injection 300 mg Twice daily from day –3 to day +30 post HCT Maraviroc reduced the growth of L-540 tumor xenografts and inhibited monocyte infiltration PMC6395337
Mice Aged mice model Subcutaneous injection 80 mg/kg/day Daily administration from P1 to P21 To study the effect of Maraviroc on bone mass and the number of TGFβ1+CCR5+ neutrophils in aged mice, results showed that Maraviroc reduced the number of these cells and increased bone mass. PMC9834218
BALB/c nude mice Chordoma xenograft model Intraperitoneal injection 10 mg/kg Once daily for 12 days MVC treatment significantly inhibited chordoma growth and lung metastasis PMC10151997

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02519777 HIV Infections Phase 4 Active, not recruiting November 30, 2020 -
NCT02333045 HIV Not Applicable Terminated(Minimal efficacy of... More >> maraviroc alone was found in preliminary data analysis of another study.) Less << - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Grady Infectious Diseases Clinic (Ponce Clinic) Atlanta, Georgia, United States, 30308 Less <<
NCT00925756 HIV Infections PHASE4 COMPLETED 2014-04-11 University Southern California... More >>, Los Angeles, California, 90033, United States|University California San Diego, San Diego, California, 92103, United States|Harbor-UCLA, Torrance, California, 90502, United States Less <<
NCT02333045 - Terminated(Minimal efficacy of... More >> maraviroc alone was found in preliminary data analysis of another study.) Less << - -
NCT00717067 Human Immunodeficiency Virus (... More >>HIV) Infection Less << Phase 4 Completed - Germany ... More >> Pfizer Investigational Site Berlin, Germany, 10117 Pfizer Investigational Site Muenchen, Germany, 81241 Less <<
NCT00717067 - Completed - -
NCT01637233 - Completed - Argentina ... More >> Hospital Ramos Mejía Buenos Aires, Argentina, C1221ADC Fundación IDEAA Buenos Aires, Argentina, C1405CKC CAICI Rosario, Argentina Thailand Chulalongkorn University Hospital Bangkok, Thailand, 10330 United Kingdom Brighton & Sussex University NHS Trust Brighton, Sussex, United Kingdom, BN21ES, Imperial Healthcare, St. Mary's Hospital London, United Kingdom, W2 Less <<
NCT01533272 HIV Infection Phase 4 Completed - Spain ... More >> Hospital Clinic de Barcelona Barcelona, Spain, 08036 Less <<
NCT02486510 HIV-1 Infection EARLY_PHASE1 TERMINATED 2025-12-15 Hospital Universitario Ramon Y... More >> Cajal, Madrid, 28034, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain Less <<
NCT00850395 - Completed - -
NCT00795444 HIV-1 Phase 2 Completed - Spain ... More >> Hospital Universitario Ramon Y Cajal Madrid, Spain, 28034 Less <<
NCT00850395 - Completed - -
NCT00808002 HIV Infections Phase 3 Completed - Spain ... More >> Hospital Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08916 Less <<
NCT00844519 - Completed - -
NCT01785810 Hematologic Malignancy Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00844519 HIV Infection ... More >> Cardiovascular Disease Inflammation HIV Infections Less << Phase 3 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94110 Less <<
NCT00634959 HIV Phase 2 Completed - United States, Alabama ... More >> Pfizer Investigational Site Birmingham, Alabama, United States, 35294-2050 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02215 Germany Pfizer Investigational Site Frankfurt, Germany, 60596 Pfizer Investigational Site Hamburg, Germany, 20099 Pfizer Investigational Site Koeln, Germany, 50931 United Kingdom Pfizer Investigational Site London, United Kingdom, NW3 2QG Pfizer Investigational Site London, United Kingdom, SW10 9NH Less <<
NCT01585753 - Completed - Argentina ... More >> Hospital General de Agudos "Dr. José María Ramos Mejía" Buenos Aires, Argentina, C1221ADC Fundacion IDEAA Buenos Aires, Argentina, C1405CKC Hospital Italiano de Buenos Aires Buenos Aires, Argentina Australia, New South Wales St. Vincent's Hospital Sydney, New South Wales, Australia, 2010 Germany Johann Wolfgang Goethe-University Hospital, Medical HIVCENTER Frankfurt, Frankfurt am Main, Germany, 60590 Thailand Chulalongkorn University Hospital Bangkok, Thailand, 10330 Less <<
NCT01776996 - - - Argentina ... More >> GSK Investigational Site Rosario, Santa Fe, Argentina, 2000 GSK Investigational Site Buenos Aires, Argentina, 1202 GSK Investigational Site Buenos Aires, Argentina, C1264AAV GSK Investigational Site Buenos Aires, Argentina, C1282AEN Belgium GSK Investigational Site Brussels, Belgium, 1000 GSK Investigational Site Gent, Belgium, 9000 GSK Investigational Site Leuven, Belgium, 3000 Italy GSK Investigational Site Milano, Lombardia, Italy, 20127 GSK Investigational Site Modena, Italy, 41124 Poland GSK Investigational Site Bydgoszcz, Poland, 85-030 Russian Federation GSK Investigational Site Moscow, Russian Federation, 105275 GSK Investigational Site Moscow, Russian Federation, 129110 GSK Investigational Site N.Novgorod, Russian Federation, 603005 GSK Investigational Site Saint-Petersburg, Russian Federation, 190103 GSK Investigational Site Smolensk, Russian Federation, 214006 GSK Investigational Site St. Petersburg, Russian Federation, 196645 South Africa GSK Investigational Site Port Elizabeth, Eastern Cape, South Africa, 6001 GSK Investigational Site Soweto, Gauteng, South Africa, 2013 GSK Investigational Site Bloemfontein, South Africa, 9301 GSK Investigational Site Dundee, South Africa, 3000 GSK Investigational Site Gauteng, South Africa, 2047 GSK Investigational Site Port Elizabeth, South Africa, 6070 GSK Investigational Site Pretoria North, South Africa, 0116 GSK Investigational Site Pretoria, South Africa, 0083 GSK Investigational Site Westdene, South Africa, 2092 Switzerland GSK Investigational Site Bern, Switzerland, CH-3010 GSK Investigational Site Lugano, Switzerland, 6900 GSK Investigational Site Zuerich, Switzerland, 8091 Less <<
NCT03118661 HIV-1-infection Phase 1 Withdrawn(No accrual to the st... More >>udy) Less << September 30, 2025 -
NCT01204905 HIV Infections Not Applicable Completed - United States, Maryland ... More >> University of Maryland, Institute of Human Virology Baltimore, Maryland, United States, 21201 Less <<
NCT03274804 Metastatic Colorectal Cancer ... More >> MSS Less << Phase 1 Active, not recruiting November 1, 2019 Germany ... More >> National Center for Tumor Diseases, University Hospital Heidelberg Heidelberg, Germany Less <<
NCT00478231 Acquired Immunodeficiency Synd... More >>rome|HIV Infection Less << PHASE3 COMPLETED 2025-09-10 Pfizer Investigational Site, S... More >>alvador, BA, 40110-160, Brazil|Pfizer Investigational Site, Brasilia, DF, 70351-580, Brazil|Pfizer Investigational Site, Belo Horizonte, MG, 30130-100, Brazil|Pfizer Investigational Site, Curitiba, PR, 80240-280, Brazil|Pfizer Investigational Site, Nova Igua?u, RJ, 26030-380, Brazil|Pfizer Investigational Site, Porto Alegre, RS, 90110-270, Brazil|Pfizer Investigational Site, Florianopolis, SC, 88025-301, Brazil|Pfizer Investigational Site, Campinas, SP, 13059-900, Brazil|Pfizer Investigational Site, Campinas, SP, 13083-887, Brazil|Pfizer Investigational Site, Ribeirao Preto, SP, 14048900, Brazil|Pfizer Investigational Site, Santo Andre, SP, 09060-650, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 01246-900, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 01307-001, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 04040-002, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 04121-000, Brazil|Pfizer Investigational Site, S?o Paulo, SP, 04231-030, Brazil Less <<
NCT00478231 Acquired Immunodeficiency Synd... More >>rome|HIV Infection Less << PHASE3 COMPLETED 2025-09-10 Pfizer Investigational Site, S... More >>alvador, BA, 40110-160, Brazil|Pfizer Investigational Site, Brasilia, DF, 70351-580, Brazil|Pfizer Investigational Site, Belo Horizonte, MG, 30130-100, Brazil|Pfizer Investigational Site, Curitiba, PR, 80240-280, Brazil|Pfizer Investigational Site, Nova Igua?u, RJ, 26030-380, Brazil|Pfizer Investigational Site, Porto Alegre, RS, 90110-270, Brazil|Pfizer Investigational Site, Florianopolis, SC, 88025-301, Brazil|Pfizer Investigational Site, Campinas, SP, 13059-900, Brazil|Pfizer Investigational Site, Campinas, SP, 13083-887, Brazil|Pfizer Investigational Site, Ribeirao Preto, SP, 14048900, Brazil|Pfizer Investigational Site, Santo Andre, SP, 09060-650, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 01246-900, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 01307-001, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 04040-002, Brazil|Pfizer Investigational Site, Sao Paulo, SP, 04121-000, Brazil|Pfizer Investigational Site, S?o Paulo, SP, 04231-030, Brazil Less <<
NCT01013987 HIV-1 Adults Patients ... More >> AIDS Triple Class Failure Less << Phase 4 Unknown - Argentina ... More >> Fundación Huésped Recruiting Ciudad de Buenos Aires, Argentina, C1202ABB Contact: María C. Magneres, MD    54-11-4981-7777 ext 114    maria.magneres@huesped.org.ar    Contact: Patricia Luz Patterson, MD    54-11-4981-7777 ext 114    patricia.patterson@huesped.org.ar    Principal Investigator: Alejandro Krolewiecki, MD Less <<
NCT01275625 HIV Phase 4 Completed - Russian Federation ... More >> Regional Center on AIDS and Infectious Diseases Prophylaxis and Control Krasnoyarsk, Russian Federation, 660049 Federal scientific and methodological center on AIDS prophylaxis and control Moscow, Russian Federation, 105275 Moscow regional center on AIDS and infectious diseases prophylaxis and control Moscow, Russian Federation, 129110 Regional Center on AIDS and Infectious Diseases Prophylaxis and Control Nizhnij Novgorod, Russian Federation, 603005 Saint-Petersburg Center on AIDS and Infectious Diseases Prophylaxis and Control Saint-Petersburg, Russian Federation, 190103 Federal State Institution Republican clinical infectious hospital of Roszdrav Saint-Petersburg, Russian Federation, 196645 Smolensk Center on AIDS and infectious diseases prophylaxis and control Smolensk, Russian Federation, 214006 Volgograd Regional Center on AIDS and Infectious Diseases Prophylaxis and Control Volgograd, Russian Federation, 400040 Less <<
NCT00988780 Immune Reconstitution Inflamma... More >>tory Syndrome HIV HIV Infections Less << Not Applicable Unknown April 2013 United States, Maryland ... More >> NIH/NIAD Bethesda, Maryland, United States, 20892 United States, Ohio Center for AIDS Research. Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania Center for Clinical Epidemiology and Biostatistics. University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, United States, 19104 HIV-1 Immunopathogenesis Laboratory. The Wistar Institute Philadelphia, Pennsylvania, United States, 19104 Mexico Hospital General de León Leon, Guanajuato, Mexico, 37230 Hospital Civil de Guadalajara Guadalajara, Jalisco, Mexico, 44280 Hospital General de México Mexico City, Mexico, 06726 Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Mexico City, Mexico, 14000 Hospital Central Dr. Ignacio Morones Prieto San Luis Potosí, Mexico, 78240 South Africa Clinical HIV Research Unit. Themba Lethu Clinic. Helen Joseph Hospital Johannesburg, Gauteng, South Africa, 2092 Less <<
NCT01680536 HIV Phase 4 Completed - United Kingdom ... More >> St Stephen's AIDS Trust London, United Kingdom, SW10 9TH Less <<
NCT01275625 - Completed - -
NCT01204905 - Completed - -
NCT03129113 Hepatic Steatosis ... More >> HIV-1-infection Less << Phase 2 Phase 3 Recruiting November 2020 United Kingdom ... More >> Royal Free Hospital Recruiting London, United Kingdom, NW3 2QG Contact: PI          St Thomas' Hospital Recruiting London, United Kingdom, SE1 9RT Contact: PI          King's College Hospital Recruiting London, United Kingdom, SE5 9RJ Contact: PI          UCL Mortimer Market Centre Recruiting London, United Kingdom, WC1E 6JB Contact: PI Less <<
NCT01597648 Infection, Human Immunodeficie... More >>ncy Virus I Less << Phase 1 Completed - -
NCT00427934 Arthritis, Rheumatoid Phase 2 Terminated(See Detailed Descri... More >>ption.) Less << - -
NCT00987948 - Completed - -
NCT00987948 HIV Infections Phase 2 Completed - United States, Hawaii ... More >> Hawaii Center for AIDS Honolulu, Hawaii, United States, 96816 Less <<
NCT00426660 HIV Infections Phase 3 Completed - -
NCT01290211 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
NCT01242579 HIV Infections Phase 1 Withdrawn(In order to focus ef... More >>forts on the combination ring formulation, IPM decided not to move forward with this trial.) Less << - -
NCT00771823 HIV Infections Phase 1 Completed - United Kingdom ... More >> Chelsea and Westminster Hospital London, United Kingdom, SW10 9TH Less <<
NCT00992654 - - - -
NCT00426660 - Completed - -
NCT00966329 HIV HIV Infec... More >>tions Less << Phase 4 Completed - Spain ... More >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Lluita contra la Sida Foundation, HIV Unit, Irsi Caixa Foundation Badalona, Barcelona, Spain, 08916 Lluita contra la Sida Foundation, HIV Unit Badalona, Barcelona, Spain, 08916 Less <<
NCT00427934 - Terminated(See Detailed Descri... More >>ption.) Less << - -
NCT01363037 HIV Infections Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Massachusetts The Fenway Institute/Fenway Community Health Boston, Massachusetts, United States, 02115 United States, Pennsylvania Magee-Womens Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00870363 - Completed - -
NCT01140412 Healthy Phase 1 Terminated(The trial premature... More >>ly terminated on November 1, 2010, due to healthy volunteer participants experiencing non-serious fosamprenavir-related skin rash.) Less << - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT00870363 HIV Infections Phase 4 Completed - United States, California ... More >> CARES Clinic Sacramento, California, United States, 95811 Less <<
NCT01345630 HIV-1 Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01367210 HIV Infection Phase 4 Terminated(Because a higher ra... More >>te of virological failures in study versus control arm.) Less << - Italy ... More >> Catholic University of Sacred Heart Rome, Italy, 00168 Less <<
NCT00782301 Hepatitis B H... More >>uman Immunodeficiency Virus Hepatitis C, Chronic Less << Phase 4 Withdrawn - United States, Florida ... More >> Pfizer Investigational Site Clearwater, Florida, United States, 33765 Pfizer Investigational Site Orlando, Florida, United States, 32803 Pfizer Investigational Site Safety Harbor, Florida, United States, 34695 Pfizer Investigational Site Wilton Manors, Florida, United States, 33305 United States, Georgia Pfizer Investigational Site Atlanta, Georgia, United States, 30308 Pfizer Investigational Site Atlanta, Georgia, United States, 30312 United States, Louisiana Pfizer Investigational Site New Orleans, Louisiana, United States, 70112 United States, Massachusetts Pfizer Investigational Site Worcester, Massachusetts, United States, 01605 Pfizer Investigational Site Worcester, Massachusetts, United States, 01655 United States, New York Pfizer Investigational Site Mt. Vernon, New York, United States, 10550 United States, Oklahoma Pfizer Investigational Site Tulsa, Oklahoma, United States, 74135 United States, Texas Pfizer Investigational Site Bellaire, Texas, United States, 77401 Pfizer Investigational Site Conroe, Texas, United States, 77301 Pfizer Investigational Site Dallas, Texas, United States, 75390 Pfizer Investigational Site Stafford, Texas, United States, 77477 Canada, British Columbia Pfizer Investigational Site Vancouver, British Columbia, Canada, V6Z 2C7 Canada, Ontario Pfizer Investigational Site Toronto, Ontario, Canada, M5G 2N2 Poland Pfizer Investigational Site Bydgoszcz, Poland, 85-030 Less <<
NCT01291459 HIV Phase 2 Unknown December 2015 France ... More >> Cannes hosipital CAnnes, France, 06400 CHU Clermont-Ferrand, France, 63003 Frejus hospital Frejus, France, 83608 Edourad Herriot hospital Lyon, France, 69003 Croix Rousse hospital Lyon, France, 69004 Ste MArguerite Hospital MArseille, France, 13009 Conception hospital Marseille, France, 13385 Hotel Dieu hospital Nantes, France, 44093 Hopital l'Archet 1 Nice, France, 06202 St Louis Hospital Paris, France, 75010 Pitie Salpetriere Hospital Paris, France, 75013 Nord Hospital St Etienne, France, 42277 Less <<
NCT01749566 HIV Phase 1 Completed - United States, Georgia ... More >> Grady Infectious Diseases Program Atlanta, Georgia, United States, 30303 Less <<
NCT01068873 HIV Infections Phase 4 Terminated(Poor enrollment) - United States, Pennsylvania ... More >> Temple General Internal Medicine Philadelphia, Pennsylvania, United States, 19140 Less <<
NCT02778204 HIV Infections Phase 1 Recruiting July 31, 2020 United States, California ... More >> University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program Recruiting La Jolla, California, United States, 92093-0672 Contact: Megan Loughran, B.A.    858-534-9218    meloughran@ucsd.edu    Usc La Nichd Crs Recruiting Los Angeles, California, United States, 90089 Contact: Eva A. Operskalski, Ph.D.    323-865-1554    eva@usc.edu    United States, Colorado Univ. of Colorado Denver NICHD CRS Recruiting Aurora, Colorado, United States, 80045 Contact: Emily Barr, C.P.N.P., C.N.M., M.S.N.    720-777-6752    emily.barr@childrenscolorado.org    United States, Illinois Rush Univ. Cook County Hosp. Chicago NICHD CRS Recruiting Chicago, Illinois, United States, 60612 Contact: Maureen McNichols, R.N., M.S.N., C.C.R.C.    312-572-4541    maureen_mcnichols@rush.edu    Lurie Children's Hospital of Chicago (LCH) CRS Recruiting Chicago, Illinois, United States, 60614-3393 Contact: Margaret Ann Sanders, M.P.H.    312-227-8275    msanders@luriechildrens.org    United States, Massachusetts Boston Medical Center Ped. HIV Program NICHD CRS Recruiting Boston, Massachusetts, United States, 02118 Contact: Debra McLaud, R.N.    617-414-5813    demclaud@bmc.org    United States, Tennessee St. Jude Children's Research Hospital CRS Recruiting Memphis, Tennessee, United States, 38105-3678 Contact: Jill Utech, M.S.N.    901-595-5059    jill.utech@stjude.org    Kenya Kenya Medical Research Institute / Walter Reed Project Clinical Research Center, Kericho CRS Recruiting Kericho, Kenya, 20200 Contact: Samwel K. Chirchir, R.N., B.Sc.    254-522-030388    Samwel.Chirchir@usamru-k.org    South Africa Soweto IMPAACT CRS Recruiting Johannesburg, Gauteng, South Africa, 1862 Contact: Nasreen Abrahams, M.B.A., B.Tech    27-11-9899700    abrahamsn@phru.co.za    Umlazi CRS Recruiting Durban, Kwa Zulu Natal, South Africa, 4001 Contact: Vani Chetty    27-31-2601998    Chettyv1@ukzn.ac.za    Thailand Siriraj Hospital ,Mahidol University NICHD CRS Recruiting Bangkok, Bangkoknoi, Thailand, 10700 Contact: Watcharee Lermankul    66-2-4197000 ext 5695    watchareeped@gmail.com    Uganda MU-JHU Research Collaboration (MUJHU CARE LTD) CRS Recruiting Kampala, Uganda Contact: Carolyne P. Onyango, MB ChB, M.S.    256-414-541044    carolonyango@mujhu.org Less <<
NCT01345630 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00864474 - Active, not recruiting December 24, 2018 -
NCT01049204 HIV Infections Phase 4 Terminated(The data from the f... More >>irst 48 patients recruited has now been analysed, and it has been determined that it is sufficient to meet the study objectives.) Less << - United Kingdom ... More >> St Stephen's Centre London, United Kingdom, SW10 9NH Less <<
NCT00993148 HIV-1 Infection ... More >> HIV Infections Less << Phase 2 Completed - United States, California ... More >> Quest Clinical Research San Francisco, California, United States United States, Florida University of Miami Miami, Florida, United States United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 CORECenter Chicago, Illinois, United States, 60612 United States, Nebraska University of Nebraska Omaha, Nebraska, United States Less <<
NCT00703586 HIV Infections PHASE1 COMPLETED 2025-05-11 Rockefeller University Hospita... More >>l, New York, New York, 10065, United States Less <<
NCT00981318 HIV Infections ... More >> Acquired Immunodeficiency Syndrome Less << Phase 4 Terminated(unable to enroll ex... More >>pected number of subjects) Less << - United States, Florida ... More >> Barry M. Rodwick, M. D. Safety Harbor, Florida, United States, 34695 Less <<
NCT00827112 Human Immunodeficiency Virus-1 Phase 2 Completed - -
NCT00993148 - Completed - -
NCT01327547 HIV Coinfection Phase 4 Completed - -
NCT02134717 Sarcoidosis Not Applicable Terminated(Poor recruitment) - United States, Pennsylvania ... More >> Dorothy P. and Richard P. Simmons center for Interstitial lung Disease at the University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00735072 HIV Infection Phase 4 Completed - United States, California ... More >> University of California San Francisco - San Francisco General Hospital San Francisco, California, United States, 94110 Stanford University Stanford, California, United States, 94305 United States, Illinois Rush University - Stroger Hospital of Cook County Chicago, Illinois, United States, 60612 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 Less <<
NCT01384682 HIV PHASE4 COMPLETED 2025-12-15 FUNCEI, Buenos Aires, Ciudad d... More >>e Buenos Aires, 1425, Argentina|Hospital Italiano de Buenos Aires, Buenos Aires, Ciudad de Buenos Aires, C1181ACH, Argentina|Hospital G de Agudos JM Ramos Mejia, Buenos Aires, Ciudad de Buenos Aires, C1221ADC, Argentina|Hospital Nacional Prof Alejandro Posadas, El Palomar, Provincia de Buenos Aires, 1684, Argentina|Hospital Dr Diego Paroissien, Isidro Casanova, Provincia de Buenos Aires, 1765, Argentina|CAICI, Rosario, Provincia de Santa Fe, S2000PBJ, Argentina|Fundacion IDEAA, Buenos Aires, C1405CKC, Argentina|Hospital Privado- Centro Medico Cordoba, Cordoba, Argentina|Holdsworth House Medical Practice, Sydney, New South Wales, 2010, Australia|St. Vincent's Hospital, Sydney, New South Wales, 2010, Australia|Royal Prince Alfred Hospital, Sydney, New South Wales, 2050, Australia|Westmead Hospital, Sydney, New South Wales, 2145, Australia|Gladstone Road Medical Centre, Bisbane, Queensland, 4101, Australia|Brisbane Sexual Health and HIV Service (formerly AMU), Brisbane, Queensland, 4000, Australia|Nambour General Hospital, Nambour, Queensland, 4560, Australia|O'Brien Street Practice, Adelaide, South Australia, 5000, Australia|Alfred Hospital, Melbourne, Victoria, 3004, Australia|Monash Medical Centre, Melbourne, Victoria, 3168, Australia|Southern Alberta Clinic, Calgary, Alberta, T2R OX7, Canada|University Health Network/Toronto General Hospital, Toronto, Ontario, M5G 2N2, Canada|Canadian Immunodeficiency Research Collaborative (CIRC) lnc (Maple Leaf Clinic), Toronto, Ontario, ON M5G 1k2, Canada|Clinic Opus/Lori, Montreal, Quebec, H3A 1T1, Canada|Fundación Arriarán, Santiago, Santiago RM, Chile|Service Maladies infectieuses et Tropicales CHR ORLEANS La SOURCE, Orleans, 45100, France|Johann Wolfgang Goethe-University Hospital, Medical HIVCENTER, Frankfurt, Frankfurt am Main, 60590, Germany|Gemeinschaftspraxis Jessen Jessen Stein, Berlin, 10777, Germany|Dienstleistung centre ID (Baumgarten, MIB medical center for infectious diseases), Berlin, 13353, Germany|University of Bonn, Med J. Immunologische Siudienzenirale, Bonn, 53127, Germany|Klinikum der Universitat Zu Koln, Cologne, 50937, Germany|Universit?tsklinikum Düsseldorf, Klinik für Gastroenterologie, Hepatologie und Infektiologie-MX- Amb, Düsseldorf, 40225, Germany|Klinik für Immunologie und Rheumatologie, Medzinische Hochschule Hannover, Hannover, 30625, Germany|Mater Misericordiae University Hospital, Dublin, 7, Ireland|Nagoya Medical Center, Nagoya, 460-0001, Japan|Hospital Civil de Guadalajara, Guadalajara, Jalisco, 44280, Mexico|Hospital General de Leon, Leon, 37320, Mexico|INCMNSZ, Mexico City, Mexico|Wojewodzki Szpital Zakazny Centrum Diagnostyki i Terapii AIDS, Warsaw, 01-201, Poland|Hospital Germans Trias i Pujol, Badalona, Catalonia, 08916, Spain|Hospital Clínic de Barcelona, Barcelona, Catalonia, 08036, Spain|Hospital de la Santa Creu i Sant Pau, Barcelona, Catalonia, 08041, Spain|Hospital La Paz,, Madrid, 28046, Spain|Hospital Principe de Asturias, Madrid, 28805, Spain|Hospital Regional Carlos Haya de Málaga, Malaga, 29010, Spain|Virgen Del Rocio University Hospital, Seville, 41013, Spain|Hospital Universitari i Politecnic La Fe, Valencia, 46026, Spain|Chulalongkorn University Hospital, Bangkok, 10330, Thailand|Western General Hospital, Edinburgh, Lothian, United Kingdom|Brighton & Sussex University NHS Trust, Brighton, Sussex, BN21ES, United Kingdom|Coventry and Warwickshire Partnership Trust, Coventry, Warwickshire, CV 1 4FS, United Kingdom|St. Mary's Hospital, Imperial College, London, W2, United Kingdom|St. Thomas's Hospital, London, United Kingdom Less <<
NCT00827112 - Completed - -
NCT00875368 HIV Infections Phase 4 Completed - Netherlands ... More >> Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 AC Academisch Medisch Centrum (AMC) Amsterdam, Netherlands, 1105AZ Slotervaartziekenhuis Amsterdam, Netherlands Rijnstate Hospital Arnhem, Netherlands Kennemer Gasthuis Haarlem, Netherlands Leids Universitair Medisch Centrum (LUMC) Leiden, Netherlands Erasmus MC Rotterdam, Netherlands, 3015GJ Maasstad Ziekenhuis Rotterdam, Netherlands Sint Elisabeth Ziekenhuis Tilburg, Netherlands Ùniversity Medical Center Utrecht Utrecht, Netherlands, 3584CX Less <<
NCT02039323 Healthy Adult Females Phase 1 Completed - United States, North Carolina ... More >> CTRC University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00735072 - Completed - -
NCT02134717 - Terminated(Poor recruitment) - -
NCT00665561 - Active, not recruiting February 26, 2019 -
NCT01719627 HIV Phase 1 Completed - Spain ... More >> Germans Trias i Pujol Hospital Badalona, Barcelona, Spain, 08916 Less <<
NCT00853840 AIDS Phase 4 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, 1070 Less <<
NCT01896921 HIV Phase 3 Recruiting December 2018 United States, Maryland ... More >> University of Maryland, Institute of Human Virology Recruiting Baltimore, Maryland, United States, 21201 Contact: Gregory Brogden, BS    410-706-1660    gbrogden@ihv.umaryland.edu    Contact: Judith Shaw    1-866-448-4448    jshaw@ihv.umaryland.edu    Principal Investigator: David Riedel, MD Less <<
NCT03178084 HIV/AIDS Phase 3 Completed - -
NCT00666705 Healthy Phase 4 Completed - United States, Connecticut ... More >> Pfizer Investigational Site New Haven, Connecticut, United States, 06511 Less <<
NCT02626923 - Completed - -
NCT01327547 - Completed - -
NCT00709111 HIV Infections COMPLETED 2025-04-10 Alabama Therapeutics CRS (5801... More >>), Birmingham, Alabama, 35294, United States|UCLA CARE Center CRS (601), Los Angeles, California, 90035, United States|Stanford CRS (501), Palo Alto, California, 94304, United States|Ucsd, Avrc Crs (701), San Diego, California, 92103, United States|Ucsf Aids Crs (801), San Francisco, California, 94110, United States|Georgetown University CRS (GU CRS) (1008), Washington, District of Columbia, 20007, United States|Univ. of Miami AIDS CRS (901), Miami, Florida, 33136, United States|The Ponce de Leon Ctr. CRS (5802), Atlanta, Georgia, 30308, United States|Northwestern University CRS (2701), Chicago, Illinois, 60611, United States|IHV Baltimore Treatment CRS (4651), Baltimore, Maryland, 21201, United States|Johns Hopkins Adult AIDS CRS (201), Baltimore, Maryland, 21205, United States|Massachusetts General Hospital ACTG CRS (101), Boston, Massachusetts, 02114, United States|Brigham and Women's Hosp. ACTG CRS (107), Boston, Massachusetts, 02115, United States|Boston Medical Center ACTG CRS (104), Boston, Massachusetts, 02118, United States|Washington University CRS (2101), Saint Louis, Missouri, 63110, United States|Cornell CRS (7804), New York, New York, 10011, United States|NY Univ. HIV/AIDS CRS (401), New York, New York, 10016, United States|AIDS Care CRS (1108), Rochester, New York, 14642, United States|Univ. of Rochester ACTG CRS (1101), Rochester, New York, 14642, United States|Unc Aids Crs (3201), Chapel Hill, North Carolina, 27516, United States|Duke Univ. Med. Ctr. Adult CRS (1601), Durham, North Carolina, 27710, United States|Univ. of Cincinnati CRS (2401), Cincinnati, Ohio, 45267, United States|MetroHealth CRS (2503), Cleveland, Ohio, 44109, United States|The Ohio State Univ. AIDS CRS (2301), Columbus, Ohio, 43210, United States|Hosp. of the Univ. of Pennsylvania CRS (6201), Philadelphia, Pennsylvania, 19104, United States|Pittsburgh CRS (1001), Pittsburgh, Pennsylvania, 15213, United States|Vanderbilt Therapeutics CRS (3652), Nashville, Tennessee, 37204, United States|Peabody Health Ctr. CRS (31443), Dallas, Texas, 75215, United States|Houston AIDS Research Team CRS (31473), Houston, Texas, 77030, United States Less <<
NCT00666705 - Completed - -
NCT00719823 Human Immunodeficiency Virus T... More >>ype 1 Less << PHASE3 WITHDRAWN 2025-05-10 -
NCT00853840 - Completed - -
NCT01009034 - Completed - Canada, Ontario ... More >> The Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Canadian Immunodeficiency Research Collaborative Toronto, Ontario, Canada, M5B1L6 Less <<
NCT00884858 HIV Infections PHASE4 COMPLETED 2025-04-11 Servizio Regionale di Immunolo... More >>gia Clinica e Tipizzazione Tissutale, Azienda Ospedaliero-Universitaria, Torrette di Ancona, AN, 60126, Italy|Clinica di Malattie Infettive, Policlinico, Universita' degli Studi, Bari, BA, 70124, Italy|Clinica di Malattie Infettive e Tropicali, Università degli Studi di Brescia, Spedali civili, Brescia, BS, 25125, Italy|Divisione di Malattie Infettive, Ospedale S. Maria Annunziata, Antella, FI, 50011, Italy|Clinica di Malattie Infettive, Ospedale San Martino, Genova, GE, 16132, Italy|Divisione di Malattie Infettive, Ospedale San Gerardo, Monza, MB, 20052, Italy|Polo di Medicina Chirurgia e Odontoiatria, Polo Didattico S. Paolo, Milano, MI, 20124, Italy|U.O di Malattie Infettive, Fondazione San Raffaele del Monte Tabor, Milano, MI, 20132, Italy|Divisione Clinicizzata di Malatie Infettive, Azienda Ospedaliera-Polo Universitario "Luigi Sacco", Milano, MI, 20157, Italy|I e II Divisione Malattie Infettive, Azienda Ospedaliera-Polo Universitario Luigi Sacco, Milano, MI, 20157, Italy|Clinica delle Malattie Infettive, Policlinico Universitario, Modena, MO, 41100, Italy|U.O. Malattie Infettive, Ospedale S. Spirito, Pescara, PE, 65100, Italy|Clinica delle Malattie Infettive, Policlinico Monteluce, Perugia, PG, 06126, Italy|Clinica delle Malattie Infettive, Policlinico "Tor Vergata", Roma, RM, 00133, Italy|III Divisione di Malattie Infettive, I.N.M.I Lazzaro Spallanzani, Roma, RM, 00149, Italy|IV Divisione di Malattie Infettive, INMI Lazzaro Spallanzani, Roma, RM, 00149, Italy|U.O. Malattie Infettive, Azienda Policlinico Umberto I, Roma, RM, 00161, Italy|Istituto Clinica delle Malattie Infettive, Università Cattolica del Sacro Cuore, Roma, RM, 00168, Italy|Clinica delle Malattie Infettive ,Ospedale Amedeo di Savoia, Torino, TO, 10149, Italy|Divisione Dipartimento Urgenze Infettivologiche ad Alta Complessità e correlate all'AIDS, Ospedale Cotugno, Napoli, 80131, Italy Less <<
NCT01009034 - Completed - -
NCT00982878 HIV Infections PHASE1 COMPLETED 2025-02-11 Imperial College Healthcare NH... More >>S Trust, London, W2 1NY, United Kingdom Less <<
NCT00709111 HIV Infections COMPLETED 2025-04-10 Alabama Therapeutics CRS (5801... More >>), Birmingham, Alabama, 35294, United States|UCLA CARE Center CRS (601), Los Angeles, California, 90035, United States|Stanford CRS (501), Palo Alto, California, 94304, United States|Ucsd, Avrc Crs (701), San Diego, California, 92103, United States|Ucsf Aids Crs (801), San Francisco, California, 94110, United States|Georgetown University CRS (GU CRS) (1008), Washington, District of Columbia, 20007, United States|Univ. of Miami AIDS CRS (901), Miami, Florida, 33136, United States|The Ponce de Leon Ctr. CRS (5802), Atlanta, Georgia, 30308, United States|Northwestern University CRS (2701), Chicago, Illinois, 60611, United States|IHV Baltimore Treatment CRS (4651), Baltimore, Maryland, 21201, United States|Johns Hopkins Adult AIDS CRS (201), Baltimore, Maryland, 21205, United States|Massachusetts General Hospital ACTG CRS (101), Boston, Massachusetts, 02114, United States|Brigham and Women's Hosp. ACTG CRS (107), Boston, Massachusetts, 02115, United States|Boston Medical Center ACTG CRS (104), Boston, Massachusetts, 02118, United States|Washington University CRS (2101), Saint Louis, Missouri, 63110, United States|Cornell CRS (7804), New York, New York, 10011, United States|NY Univ. HIV/AIDS CRS (401), New York, New York, 10016, United States|AIDS Care CRS (1108), Rochester, New York, 14642, United States|Univ. of Rochester ACTG CRS (1101), Rochester, New York, 14642, United States|Unc Aids Crs (3201), Chapel Hill, North Carolina, 27516, United States|Duke Univ. Med. Ctr. Adult CRS (1601), Durham, North Carolina, 27710, United States|Univ. of Cincinnati CRS (2401), Cincinnati, Ohio, 45267, United States|MetroHealth CRS (2503), Cleveland, Ohio, 44109, United States|The Ohio State Univ. AIDS CRS (2301), Columbus, Ohio, 43210, United States|Hosp. of the Univ. of Pennsylvania CRS (6201), Philadelphia, Pennsylvania, 19104, United States|Pittsburgh CRS (1001), Pittsburgh, Pennsylvania, 15213, United States|Vanderbilt Therapeutics CRS (3652), Nashville, Tennessee, 37204, United States|Peabody Health Ctr. CRS (31443), Dallas, Texas, 75215, United States|Houston AIDS Research Team CRS (31473), Houston, Texas, 77030, United States Less <<
NCT02346084 HIV/AIDS Phase 1 Completed - United States, Pennsylvania ... More >> Magee Women's Hospital of UPMC Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02799888 Graft-versus-host Disease ... More >> Hematopoietic Stem Cell Transplantation Less << Phase 2 Unknown April 2017 China, Beijing ... More >> Department of Hematopoietic Stem Cell Transplantation Recruiting Beijing, Beijing, China, 100071 Less <<
NCT01276236 Kaposi's Sarcoma PHASE2 COMPLETED 2015-04-30 San Francisco General Hospital... More >>, Clinical Trials Unit, San Francisco, California, 94110, United States Less <<
NCT00821535 Human Immunodeficiency Virus (... More >>HIV) Infection Less << Phase 1 Completed - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT01597895 Healthy Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, B-1070 Less <<
NCT01348308 HIV-1 Infection ... More >> AIDS Less << Phase 3 Completed - France ... More >> Hôpital Henri Mondor Creteil, France, 94010 Less <<
NCT01056874 Healthy HIV I... More >>nfections Less << Phase 1 Completed - Singapore ... More >> Pfizer Investigational Site Singapore, Singapore, 188770 Less <<
NCT00791700 Human Immunodeficiency Virus PHASE2 UNKNOWN 2023-06-30 Children's Hospital Los Angele... More >>s, Los Angeles, California, 90027, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|Alfred I. DuPont Hospital for Children, Wilmington, Delaware, 19803, United States|Children's National Medical Center, Washington, District of Columbia, 20010, United States|Rainbow Center at University of Florida Health, Jacksonville, Florida, 32209, United States|University of Miami Miller School of Medicine, Miami, Florida, 33136, United States|University of South Florida, Tampa, Florida, 33612, United States|Grady Health System, IDP, Atlanta, Georgia, 30308, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30322, United States|Pediatric Infectious Disease Clinic, Jackson, Mississippi, 39213, United States|Batson Specialty Clinic, Jackson, Mississippi, 39216, United States|University of Mississippi, Jackson, Mississippi, 39216, United States|Cincinnati Center for Clinical Research, Cincinnati, Ohio, 45206, United States|Children's Medical Center of Dallas, Dallas, Texas, 75235, United States|Children's Memorial Hermann Hospital, Houston, Texas, 77030, United States|UT Physician, Houston, Texas, 77030, United States|VCU Health System Clinical Research Services, Richmond, Virginia, 23298, United States|Virginia Commonwealth University, Richmond, Virginia, 23298, United States|Instituto de Infectologia Emilio Ribas, S?o Paulo, SP, 01246-900, Brazil|Condomínio Edifício Parque Paulista, S?o Paulo, 01416-000, Brazil|Clinica Pediatrica Azienda Ospedaliera di Padova, Padova, 35128, Italy|Farmacia Interna, Padova, 35128, Italy|IRCCS Ospedale Pediatrico Bambino Gesu, Roma, 00165, Italy|Struttura Complessa a Direzione Universitaria Immunologia, Reumatologia e Malattie Infettive, Torino, 10126, Italy|Hospital Infantil de Mexico Federico Gomez, Mexico, DF, 06720, Mexico|Centro Hospitalar Universitario do Algarve, EPE, Faro, 8000-386, Portugal|Centro Hospitalar de Lisboa Central, EPE, Lisboa, 1169-045, Portugal|Centro Hospitalar de Lisboa Norte, EPE, Lisboa, 1649-035, Portugal|Hospital S. Jo?o, E.P.E, Porto, 4202-451, Portugal|Hospital San Juan Research Unit, San Juan, 00935, Puerto Rico|Iatros International, Bloemfontein, FREE State, 9301, South Africa|Lakeview Hospital, Benoni, Gauteng, 1501, South Africa|Dr George Mukhari Hospital, Ga-Rankuwa, Gauteng, 0208, South Africa|Dr. Jan Fourie Medical Centre, Dundee, Kwazulu-natal, 3000, South Africa|Embassy Drive Medical Center, Pretoria, 0083, South Africa|Hospital Sant Joan de Deu, Esplugues De Llobregat, Barcelona, 08950, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Muang, Chiang MAI, 50200, Thailand|Department of Pediatric, Faculty of Medicine, Khon Kaen University, Muang, Khon Kaen, 40002, Thailand|The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT),, Bangkok, 10330, Thailand|Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Bangkok, 10700, Thailand Less <<
NCT01420523 Human Immunodeficiency Virus ... More >> Lipohypertrophy Less << Phase 2 Terminated - France ... More >> Hôpital Pitié Salpétrière Paris, France, 75013 Less <<
NCT01235013 HIV-1 Infection PHASE4 UNKNOWN - Hospital Clínic i Provincial, ... More >>Barcelona, 08036, Spain Less <<
NCT01348763 HIV Phase 1 Completed - United Kingdom ... More >> Imperial College Healthcare NHS Trust London, United Kingdom, W2 1NY Less <<
NCT00944541 HIV Infection ... More >> HIV Infections Less << Phase 2 Completed - France ... More >> French National Agency for Research on AIDS and Viral Hepatits Paris, France, 75013 Less <<
NCT00791700 Human Immunodeficiency Virus PHASE2 UNKNOWN 2023-06-30 Children's Hospital Los Angele... More >>s, Los Angeles, California, 90027, United States|Children's Hospital of Orange County, Orange, California, 92868, United States|Alfred I. DuPont Hospital for Children, Wilmington, Delaware, 19803, United States|Children's National Medical Center, Washington, District of Columbia, 20010, United States|Rainbow Center at University of Florida Health, Jacksonville, Florida, 32209, United States|University of Miami Miller School of Medicine, Miami, Florida, 33136, United States|University of South Florida, Tampa, Florida, 33612, United States|Grady Health System, IDP, Atlanta, Georgia, 30308, United States|Children's Healthcare of Atlanta, Atlanta, Georgia, 30322, United States|Pediatric Infectious Disease Clinic, Jackson, Mississippi, 39213, United States|Batson Specialty Clinic, Jackson, Mississippi, 39216, United States|University of Mississippi, Jackson, Mississippi, 39216, United States|Cincinnati Center for Clinical Research, Cincinnati, Ohio, 45206, United States|Children's Medical Center of Dallas, Dallas, Texas, 75235, United States|Children's Memorial Hermann Hospital, Houston, Texas, 77030, United States|UT Physician, Houston, Texas, 77030, United States|VCU Health System Clinical Research Services, Richmond, Virginia, 23298, United States|Virginia Commonwealth University, Richmond, Virginia, 23298, United States|Instituto de Infectologia Emilio Ribas, S?o Paulo, SP, 01246-900, Brazil|Condomínio Edifício Parque Paulista, S?o Paulo, 01416-000, Brazil|Clinica Pediatrica Azienda Ospedaliera di Padova, Padova, 35128, Italy|Farmacia Interna, Padova, 35128, Italy|IRCCS Ospedale Pediatrico Bambino Gesu, Roma, 00165, Italy|Struttura Complessa a Direzione Universitaria Immunologia, Reumatologia e Malattie Infettive, Torino, 10126, Italy|Hospital Infantil de Mexico Federico Gomez, Mexico, DF, 06720, Mexico|Centro Hospitalar Universitario do Algarve, EPE, Faro, 8000-386, Portugal|Centro Hospitalar de Lisboa Central, EPE, Lisboa, 1169-045, Portugal|Centro Hospitalar de Lisboa Norte, EPE, Lisboa, 1649-035, Portugal|Hospital S. Jo?o, E.P.E, Porto, 4202-451, Portugal|Hospital San Juan Research Unit, San Juan, 00935, Puerto Rico|Iatros International, Bloemfontein, FREE State, 9301, South Africa|Lakeview Hospital, Benoni, Gauteng, 1501, South Africa|Dr George Mukhari Hospital, Ga-Rankuwa, Gauteng, 0208, South Africa|Dr. Jan Fourie Medical Centre, Dundee, Kwazulu-natal, 3000, South Africa|Embassy Drive Medical Center, Pretoria, 0083, South Africa|Hospital Sant Joan de Deu, Esplugues De Llobregat, Barcelona, 08950, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Muang, Chiang MAI, 50200, Thailand|Department of Pediatric, Faculty of Medicine, Khon Kaen University, Muang, Khon Kaen, 40002, Thailand|The HIV Netherlands Australia Thailand Research Collaboration (HIV-NAT),, Bangkok, 10330, Thailand|Department of Pediatrics, Faculty of Medicine, Siriraj Hospital, Bangkok, 10700, Thailand Less <<
NCT02480894 Infection, Human Immunodeficie... More >>ncy Virus Less << Phase 1 Completed - United States, Texas ... More >> GSK Investigational Site San Antonio, Texas, United States, 78209 Less <<
NCT01449006 Human Immunodeficiency Virus (... More >>HIV)|HIV Associated Neurocognitive Disorders (HAND) Less << PHASE4 COMPLETED 2025-09-14 St. Vincent's Hospital, Sydney... More >>, New South Wales, 2010, Australia|The Alfred Hospital, Melbourne, Victoria, 3181, Australia Less <<
NCT03402815 HIV Infection With Other Condi... More >>tions Cardiovascular Risk Factor Atherosclerosis Inflammation Less << Phase 4 Completed - Italy ... More >> Elisabetta Schiaroli Perugia, Italy, 06126 Less <<
NCT00948753 Graft-versus-host Disease ... More >> Hematopoietic Stem Cell Transplantation Less << Phase 1 Phase 2 Active, not recruiting - -
NCT01894776 HIV Infection ... More >> HIV-1 Infection Mycobacterium Avium Complex (MAC) Less << Phase 1 Completed - Canada, Ontario ... More >> The Ottawa Hospital -General Campus Ottawa, Ontario, Canada, K1H 8L6 Less <<
NCT01449006 Human Immunodeficiency Virus (... More >>HIV)|HIV Associated Neurocognitive Disorders (HAND) Less << PHASE4 COMPLETED 2025-09-14 St. Vincent's Hospital, Sydney... More >>, New South Wales, 2010, Australia|The Alfred Hospital, Melbourne, Victoria, 3181, Australia Less <<
NCT02625207 Healthy Subjects Phase 1 Completed - United States, Connecticut ... More >> Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States, 06511 Less <<
NCT00775294 HIV/AIDS PHASE1 COMPLETED 2025-03-10 UNC Hospitals CTRC, Chapel Hil... More >>l, North Carolina, 27514, United States Less <<
NCT02990312 Hiv Kidney Tr... More >>ansplant HIV Reservoir CCR5 Less << Phase 4 Recruiting July 2020 United States, Maryland ... More >> Institute of human virology Recruiting Baltimore, Maryland, United States, 21201 Contact: Jennifer Husson, MD    410-706-6973    Jhusson@ihv.umaryland.edu    Contact: Ilise Marrazzo    4107062564    IMarrazzo@ihv.umaryland.edu Less <<
NCT01866267 Human Immunodeficiency Virus|A... More >>IDS Less << PHASE4 COMPLETED 2025-06-14 St. Hope Foundation, Inc., Bel... More >>laire, Texas, 77401, United States Less <<
NCT02625207 - Completed - -
NCT01627717 Healthy Phase 1 Completed - Canada, Quebec ... More >> Centre Hospitalier de l'Université de Montréal Montréal, Quebec, Canada, H2W 1T8 Less <<
NCT01133210 Hypertriglyceridemia Phase 1 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT02159027 AIDS Dementia Complex Phase 2 Phase 3 Recruiting December 2018 United States, Hawaii ... More >> Clint Spencer Clinic, Hawaii Center for AIDS, University of Hawaii Recruiting Honolulu, Hawaii, United States, 96813 Contact: Debra Ogata-Arakaki, R.N.    808-692-1332    ogataara@hawaii.edu    Contact: Nancy Hanks, R.N.    808-692-1336    nhanks@hawaii.edu    Principal Investigator: Cecilia M. Shikuma, M.D.          Sub-Investigator: Dominic Chow, M.D. Ph.D.          Puerto Rico Puerto Rico Clinical and Translational Research Consortium Recruiting San Juan, Puerto Rico, 00936 Contact: Valerie E Wojna, MD    7877586250    valerie.wojna1@upr.edu    Contact: Miriam Matos, MD    7877590306 ext 221    miriam.matos@upr.edu Less <<
NCT01428986 HIV Infections|AIDS COMPLETED 2025-03-14 National Center for Global Hea... More >>lth and Medicine, Shinjuku, Tokyo, 1628655, Japan Less <<
NCT01190293 HIV Infection PHASE4 COMPLETED 2025-03-12 St Stephen's Centre, London, S... More >>W109NH, United Kingdom Less <<
NCT02167451 Diagnoses That Require Stem Ce... More >>ll Transplant|Graft Versus Host Disease (GVHD) Less << PHASE1|PHASE2 TERMINATED 2025-09-18 Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less <<
NCT03172026 Stroke Phase 2 Phase 3 Recruiting December 2019 United States, California ... More >> California Rehabilitation Institute Recruiting Los Angeles, California, United States, 90067 United States, New York Burke Rehabilitation Center Not yet recruiting White Plains, New York, United States, 10605 Less <<
NCT01980329 Cytochrome P450 CYP3A5 Enzyme ... More >>Polymorphism|Healthy Subjects|Pharmacokinetics of Maraviroc Less << PHASE1 COMPLETED 2025-03-14 The Johns Hopkins University S... More >>chool of Medicine Division of Clinical Pharmacology, Baltimore, Maryland, 21210, United States Less <<
NCT02934022 HIV Infection COMPLETED 2025-12-14 VA Long Beach Healthcare Syste... More >>m, Long Beach, California, 90822, United States Less <<
NCT02881762 Hepatitis C|Human Immunodefici... More >>ency Virus Less << PHASE4 COMPLETED 2019-03-27 Institute of Human Virology at... More >> the University of Maryland School of Medicine, Baltimore, Maryland, 21201, United States Less <<
NCT03708861 HIV Infection Phase 3 Withdrawn December 2017 Italy ... More >> University of Torino Torino, Italy Less <<
NCT01389063 Endothelial Dysfunction PHASE4 UNKNOWN 2025-10-14 University Medical Center Utre... More >>cht, Utrecht, 3584CX, Netherlands Less <<
NCT00801515 HIV NO_LONGER_AVAILABLE 2025-07-11 Pfizer Investigational Site, M... More >>ontreal, Quebec, H3G 1A4, Canada Less <<
NCT01736813 Colorectal Cancer|Neoplasm Met... More >>astasis|Liver Metastases Less << COMPLETED 2025-09-14 National Center for Tumor Dise... More >>ases, Department of Medical Oncology, Heidelberg, Baden-Württemberg, 69120, Germany Less <<
NCT04966429 Post Stroke Cognitive Impairme... More >>nt Less << PHASE2 UNKNOWN 2025-06-24 Tel Aviv Sourasky Medical Cent... More >>er, Tel Aviv, Israel Less <<
NCT04435522 COVID PHASE1 COMPLETED 2020-12-31 Rhode Island Hospital, Provide... More >>nce, Rhode Island, 02908, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.95mL

0.39mL

0.19mL

9.73mL

1.95mL

0.97mL

19.47mL

3.89mL

1.95mL

References

[1]Neff CP, Kurisu T, et al. A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice. PLoS One. 2011;6(6):e20209.

[2]Dorr P, Westby M, et al. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother. 2005 Nov;49(11):4721-32.

[3]Mencarelli A, Graziosi L, et al. CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. Transl Oncol. 2013 Dec 1;6(6):784-93. eCollection 2013 Dec 1.

[4]Nayak SU, Cicalese S, et al. Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist. Brain Behav Immun. 2020 Jan;83:288-292.

[5]UK-427857

[6]Woollard SM, Kanmogne GD. Maraviroc: a review of its use in HIV infection and beyond. Drug Des Devel Ther. 2015 Oct 1;9:5447-68.

[7]Dorr P, Westby M, Dobbs S, Griffin P, Irvine B, Macartney M, Mori J, Rickett G, Smith-Burchnell C, Napier C, Webster R, Armour D, Price D, Stammen B, Wood A, Perros M. Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother. 2005 Nov;49(11):4721-32.

[8]Arberas H, Guardo AC, Bargalló ME, Maleno MJ, Calvo M, Blanco JL, García F, Gatell JM, Plana M. In vitro effects of the CCR5 inhibitor maraviroc on human T cell function. J Antimicrob Chemother. 2013 Mar;68(3):577-86.

[9]Neff CP, Kurisu T, Ndolo T, Fox K, Akkina R. A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice. PLoS One. 2011;6(6):e20209.

[10]Ochoa-Callejero L, Pérez-Martínez L, Rubio-Mediavilla S, Oteo JA, Martínez A, Blanco JR. Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model. PLoS One. 2013;8(1):e53992.

 

Historical Records

Categories